Koninklijke Philips | PHG - Selling And Administration Expenses


Koninklijke Philips reported EUR1.52B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Baxter International USD 728M 33M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Boston Scientific USD 1.78B 53M Mar/2026
Danaher USD 1.86B 166M Mar/2026
Demant DKK 6.09B 135M Dec/2025
Dexcom USD 349.7M 49.8M Mar/2026
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Fresenius EUR 819M 143M Dec/2025
General Electric Aerospace USD 1.08B 496M Mar/2026
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 297.77M 20.7M Mar/2026
GN Store Nord DKK 763M 688M Mar/2026
Hitachi JPY 571.08B 79.7B Mar/2026
Idexx Laboratories USD 299.85M 24.18M Mar/2026
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Koninklijke Philips EUR 1.52B 142.19M Dec/2025
Masimo USD 143.4M 15.4M Mar/2026
Medtronic 2.96B 9M Dec/2025
Philips EUR 1.18B 121M Mar/2026
ResMed USD 279.8M 1.4M Mar/2026
Smith & Nephew USD 1.42B 65M Dec/2025
Steris USD 351.8M 500K Mar/2026
Stryker USD 2.15B 17M Mar/2026
Teleflex USD 226.01M 3.64M Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026